Drugplain

Ery-Ped 200 mg/5mL

Erythromycin Ethylsuccinate · SUSPENSION · Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)

No Recall History
Plain English

Ery-Ped is a suspension containing erythromycin ethylsuccinate at 200 mg/5mL, taken oral. Manufactured by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals).

Key Facts

Brand Name
Ery-Ped
Generic Name
Erythromycin Ethylsuccinate
NDC Code (Product)
24338-132
Manufacturer
Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Strength
200 mg/5mL
Dosage Form
SUSPENSION
Route
ORAL
Marketing Status
Application #
NDA050207
Marketing Start
07/05/2011

Recall History

No Recall History

Frequently Asked Questions

What is Ery-Ped used for?

Ery-Ped contains Erythromycin Ethylsuccinate. It is a suspension taken oral. Consult your doctor for specific uses.

Is Ery-Ped a controlled substance?

Ery-Ped is not classified as a controlled substance by the DEA.

What is the generic name for Ery-Ped?

The generic name for Ery-Ped is Erythromycin Ethylsuccinate. There are 10 other brand versions of Erythromycin Ethylsuccinate.

What is the NDC code for Ery-Ped 200 mg/5mL?

The NDC (National Drug Code) for Ery-Ped 200 mg/5mL is 24338-132, listed by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals).